Type 2 Diabetes Mellitus — Intergenerational mHealth Diabetes Program OPPORTUNITIES PROGRAM IN TAIWAN
Citation(s)
International Diabetes Federation (2013) Diabetes: Facts and Figures. Retrieved from http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures Santos-Longhurst, A. (2014). Type 2 Diabetes Statistics and Facts. Retrieved from http://www.healthline.com/health/type-2-diabetes/statistics#2 Gregg, E. W., Mangione, C. M., Cauley, J. A., Thompson, T. J., Schwartz, A. V., Ensrud, K. E., & Nevitt, M. C. (2002). Diabetes and incidence of functional disability in older women. Diabetes Care, 25(1), 61-67. Gregg, E. W., Breckles, G. L. A., Williamson, D. E., Leveille, S. G., Langlois, J. A., Engelgau, M. M., Venkat Narayan, K. M. (2000). Diabetes and physical disability among older U.S. adults. Diabetes Care, 23(9), 1272-1277. Gregg, E. W., Breckles, G. L. A., Williamson, D. E., Leveille, S. G., Langlois, J. A., Engelgau, M. M., Venkat Narayan, K. M. (2000). Diabetes and physical disability among older U.S. adults. Diabetes Care, 23(9), 1272-1277. Glasgow, R. E., Kurz, D., King, D., Faber, A. J., Halterman, E., Woolley, T. Toobert, D. J., Strycker, L. A., Estabrooks, P. A., Osuna, D., & Ritzwoller, D. (2012). Twelve-month outcomes of an internet-based diabetes self-management support program. Patient Education and Counseling, 87, 81-92 Yo, N. C. (2014). One in every ten people is living with diabetes mellitus. Retrieved from http://www.tpuca.org/news_list/show/316.html World People News. (2014). Diabetes has been ranked as the fourth leading causes of death in Taiwan. Retrieved from http://www.worldpeoplenews.com/category/2/6 Ministry of Health and Welfare. (2014). Diabetes shared network. Retrieved from http://www.tpuca.org/news_list/show/316.html
Intergenerational Mobile Technology Opportunities Program (IMTOP) in Taiwan
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
